Cargando…
Astragaloside IV Regulates Insulin Resistance and Inflammatory Response of Adipocytes via Modulating CTRP3 and PI3K/AKT Signaling
INTRODUCTION: Emerging evidence showed that adipocytes are important regulators in controlling insulin resistance in type 2 diabetes mellitus (T2DM). So far, compounds isolated from natural plants have been widely studied for their roles in alleviating T2DM-associated complications. This work evalua...
Autores principales: | Zhang, Yue, Xu, Guangning, Huang, Baoyi, Chen, Dongni, Ye, Renqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663774/ https://www.ncbi.nlm.nih.gov/pubmed/36103112 http://dx.doi.org/10.1007/s13300-022-01312-1 |
Ejemplares similares
-
Astragaloside IV combating liver cirrhosis through the PI3K/Akt/mTOR signaling pathway
por: Wei, Rendong, et al.
Publicado: (2019) -
ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signaling
por: Li, Xiaoming, et al.
Publicado: (2017) -
Astragaloside IV alleviates myocardial ischemia-reperfusion injury in rats through regulating PI3K/AKT/GSK-3β signaling pathways
por: Wei, Dajun, et al.
Publicado: (2019) -
Astragaloside IV Enhances Melanogenesis via the AhR-Dependent AKT/GSK-3β/β-Catenin Pathway in Normal Human Epidermal Melanocytes
por: Liu, Baoyi, et al.
Publicado: (2020) -
Protective Effects of Astragaloside IV on Uric Acid-Induced Pancreatic β-Cell Injury through PI3K/AKT Pathway Activation
por: Jiang, Zhenhuan, et al.
Publicado: (2022)